Reactivation of hepatitis B in a long-term anti-HBS-positive patient with aids following lamivudine withdrawal

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 306-309

  Altfeld, Marcus ^a   Rockstroh, Jurgen K ^b   Addo, Marylyn ^b   Kupfer, Bernd ^b   Pult, Irmgard ^b   Will, Hans ^b   Spengler, Ulrich ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b NONE

Author keywords

AIDS; Hepatitis B; HIV; Lamivudine; Reactivation

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; INDINAVIR; LAMIVUDINE; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; HEPATITIS B; HOMOSEXUALITY; HUMAN; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL;

EID: 0032147074     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80017-2     Document Type: Article

References (21)

1. Saillour F, Dabis F, Dupon M, Lacost D, Trimoulet P, Rispal P, et al. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. BMJ. 313:1996;461-464.
2. Francisoi D, Baldelli F, Papili R, Stagni G, Pauluzzi S. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients. Eur J Epidemiol. 11:1995;123-126.
3. Vento S, Di Pierri G, Luzzati R, Cruciani M, Garofano T, Mengoli C, et al. Clinical reactivation of hepatitis B in anti-HBs positive patients with AIDS. Lancet. i:1989;332-333.
4. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 93:1994;230-239.
5. Rethermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med. 2:1996;1104-1108.
6. Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol. 27:1997;251-258.
7. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest. 98:1996;1185-1194.
8. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol. 25:1996;639-643.
9. Elghouzzi MH, Courouce AM, Magnius LO, Lunel F, Lapierre V. Transmission of hepatitis B virus by HBV-negative blood transfusion [letter]. Lancet. 346:1995;964.
10. Wachs ME, Amed WJ, Ascher NL, Bretan PN, Emond J, Lake JR, et al. The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM (-) organ donors. Transplantation. 59:1995;230-234.
11. Chazouilleres O, Mamish D, Kim M, Carey F, Ferell L, Roberts JP, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet. 343:1994;142-146.
12. Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 26:1997;517-526.
13. Lane HC, Masur, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with acquired immunodeficiency syndrome. N Engl J Med. 309:1983;453-458.
14. Biggar RJ, Goedert JJ, Hoofnagel JH. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV [letter]. N Engl J Med. 316:1987;630-631.
15. Laukamm-Josten U, Müller O, Biezle U, Feldmeier H, Uy A, Guggenmoos-Holzmann I. Decline of naturally acquired antibodies to hepatitis B surface antigen in HIV-1 infected homosexual men [letter]. AIDS. 2:1988;400-401.
16. Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology. 100:1991;1432-1434.
17. Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 100:1991;182-188.
18. Martin BA, Rowe JM, Kouides PA, DiPersio JF. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone-Marrow-Transplant. 15:1995;145-148.
19. Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′ - dideoxy- 3′- thiacytidine and related analogues. Proc Natl Acad Sci USA. 88:1991;8495-8499.
20. Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med. 125:1996;705-712.
21. Honkoop P, de Man RA, Heijtink RA, Schalm SW. Hepatitis B reactivation after lamivudine [letter]. Lancet. 346:1995;1156-1157.